Background. New, simple, and better-performing diagnostic tools are needed for the diagnosis of tuberculosis (TB). Much effort has been invested in developing an antibody-based test for TB, but to date, no such test has performed with sufficient sensitivity and specificity. A key question remaining is the extent to which the disappointing performance of current tests is associated with a high background prevalence of latent TB.Methods. We compared Mycobacterium tuberculosis-specific ESAT-6 and CFP-10 antibody responses in a total of 565 human serum samples from M. tuberculosis-uninfected donors and donors with latent infection, as well as samples from patients with active TB. Our study included samples from 4 countries, representing environ...
Tuberculosis (TB) is the second leading cause of death from an infectious disease worldwide and rema...
Background. Development of rapid diagnostic tests for tuberculosis is a global priority. A whole pr...
BACKGROUND:Tuberculosis (TB) remains a global health threat with 9 million new cases and 1.4 million...
Serological antibody profiling of tuberculosis (TB) patients and household contacts with latent TB i...
BackgroundImproved systematic screening of high-risk groups is a key component of the tuberculosis (...
Objectives: The serological antibody detection tests offer several advantages for the rapid diagnosi...
Background Developing rapid diagnostic tests for tuberculosis (TB) is a global priority. A whole pro...
The global tuberculosis epidemic results in nearly 2 million deaths and 9 million new cases of the d...
<div><p>Background</p><p>Improved systematic screening of high-risk groups is a key component of the...
BACKGROUND: Development of rapid diagnostic tests for tuberculosis is a global priority. A whole pro...
New tests to diagnose active tuberculosis (TB) that are simple, rapid and inexpensive, yet sensitiv...
Tuberculosis (TB) still represents a monumental problem, with more than two million deaths every yea...
Current routine diagnostic tests for tuberculosis (TB) due to Mycobacterium tuberculosis (MTB) infec...
Background and objective:Serological test has become an important tool in the diagnosis of TB cases....
BACKGROUND: The global tuberculosis epidemic results in nearly 2 million deaths and 9 million new ca...
Tuberculosis (TB) is the second leading cause of death from an infectious disease worldwide and rema...
Background. Development of rapid diagnostic tests for tuberculosis is a global priority. A whole pr...
BACKGROUND:Tuberculosis (TB) remains a global health threat with 9 million new cases and 1.4 million...
Serological antibody profiling of tuberculosis (TB) patients and household contacts with latent TB i...
BackgroundImproved systematic screening of high-risk groups is a key component of the tuberculosis (...
Objectives: The serological antibody detection tests offer several advantages for the rapid diagnosi...
Background Developing rapid diagnostic tests for tuberculosis (TB) is a global priority. A whole pro...
The global tuberculosis epidemic results in nearly 2 million deaths and 9 million new cases of the d...
<div><p>Background</p><p>Improved systematic screening of high-risk groups is a key component of the...
BACKGROUND: Development of rapid diagnostic tests for tuberculosis is a global priority. A whole pro...
New tests to diagnose active tuberculosis (TB) that are simple, rapid and inexpensive, yet sensitiv...
Tuberculosis (TB) still represents a monumental problem, with more than two million deaths every yea...
Current routine diagnostic tests for tuberculosis (TB) due to Mycobacterium tuberculosis (MTB) infec...
Background and objective:Serological test has become an important tool in the diagnosis of TB cases....
BACKGROUND: The global tuberculosis epidemic results in nearly 2 million deaths and 9 million new ca...
Tuberculosis (TB) is the second leading cause of death from an infectious disease worldwide and rema...
Background. Development of rapid diagnostic tests for tuberculosis is a global priority. A whole pr...
BACKGROUND:Tuberculosis (TB) remains a global health threat with 9 million new cases and 1.4 million...